Download PDF
Semin Respir Crit Care Med 2016; 37(06): 799-805
DOI: 10.1055/s-0036-1592313
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Community-acquired Pneumonia: A Global Perspective

Grant W. Waterer
1   Department of Medicine, University of Western Australia, Perth, Australia
2   Department of Medicine, Northwestern University, Chicago, Illinois
› Author Affiliations
Further Information

Publication History

Publication Date:
13 December 2016 (online)

    Permissions and Reprints

Abstract

Community-acquired pneumonia (CAP) is a global disease responsible for a large proportion of deaths and having significant economic cost. As diagnostic tools have increased in sensitivity, our understanding of the etiology of CAP has begun to change with a significant increase in confirmed viral infections and the recognition that multiple pathogens are frequently present. Empiric therapy remains the standard of care and guidelines are mostly based on published data from the United States or Europe. Blindly applying guidelines without any consideration of local etiological differences can lead to a risk of under or overtreatment. Several pathogens are particularly problematic in the setting of CAP in some regions as they are not covered by standard guidelines; in particular, Mycobacterium tuberculosis, Burkholderia pseudomallei, and Acinetobacter baumanii. Overtreatment of patients meeting guideline criteria for healthcare-associated pneumonia is also a problem as this categorization probably only applies to a limited number of areas in the United States. New pathogens are emerging more frequently, as evidenced by severe acute respiratory syndrome, Middle East respiratory syndrome, influenza A H1N1 09, and avian influenza, all of which have global ramifications and good clinicians need to stay informed of evolving threats. There are clearly differences in outcomes from CAP across the globe, but accurately comparing them is difficult given the vast differences in age, comorbidities, and access to healthcare. Improved quality of outcome databases will be a key driver of quality improvement in coming years.

Keywords

community-acquired pneumonia - etiology - empiric therapy - guidelines
 

  • References

  • 1 World Health Organisation. Pneumonia is the leading cause of death in children. Available online at http://www.who.int/maternal_child_adolescent/news_events/news/2011/pneumonia/en/ . Accessed April 25, 2016.
    PubMedGoogle Scholar
  • 2 Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 2008; 86 (5) 408-416
    CrossrefPubMedGoogle Scholar
  • 3 World Health Organisation. The top 10 causes of death. Avaiable online at http://www.who.int/mediacentre/factsheets/fs310/en/ . Accessed May 5, 2016.
    PubMedGoogle Scholar
  • 4 Jain S, Self WH, Wunderink RG , et al; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 2015; 373 (5) 415-427
    CrossrefPubMedGoogle Scholar
  • 5 Jain S, Williams DJ, Arnold SR , et al; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 2015; 372 (9) 835-845
    CrossrefPubMedGoogle Scholar
  • 6 Azmi S, Aljunid SM, Maimaiti N , et al. Assessing the burden of pneumonia using administrative data from Malaysia, Indonesia, and the Philippines. Int J Infect Dis 2016; 49: 87-93
    CrossrefPubMedGoogle Scholar
  • 7 Rozenbaum MH, Mangen MJ, Huijts SM, van der Werf TS, Postma MJ. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: a nationwide retrospective claims database analysis. Vaccine 2015; 33 (28) 3193-3199
    CrossrefPubMedGoogle Scholar
  • 8 Ewig S, Birkner N, Strauss R , et al. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009; 64 (12) 1062-1069
    CrossrefPubMedGoogle Scholar
  • 9 Takahashi K, Suzuki M, Minh N , et al. The incidence and aetiology of hospitalised community-acquired pneumonia among Vietnamese adults: a prospective surveillance in Central Vietnam. BMC Infect Dis 2013; 13: 296
    CrossrefPubMedGoogle Scholar
  • 10 Zingone F, Abdul Sultan A, Crooks CJ, Tata LJ, Ciacci C, West J. The risk of community-acquired pneumonia among 9803 patients with coeliac disease compared to the general population: a cohort study. Aliment Pharmacol Ther 2016; 44 (1) 57-67
    CrossrefPubMedGoogle Scholar
  • 11 Mortensen EM, Kapoor WN, Chang CC, Fine MJ. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis 2003; 37 (12) 1617-1624
    CrossrefPubMedGoogle Scholar
  • 12 Waterer GW, Kessler LA, Wunderink RG. Medium-term survival after hospitalization with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169 (8) 910-914
    CrossrefPubMedGoogle Scholar
  • 13 Corrales-Medina VF, Alvarez KN, Weissfeld LA , et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA 2015; 313 (3) 264-274
    CrossrefPubMedGoogle Scholar
  • 14 Corrales-Medina VF, Taljaard M, Yende S , et al. Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults. Am Heart J 2015; 170 (2) 306-312
    CrossrefPubMedGoogle Scholar
  • 15 Honselmann KC, Buthut F, Heuwer B , et al. Long-term mortality and quality of life in intensive care patients treated for pneumonia and/or sepsis: Predictors of mortality and quality of life in patients with sepsis/pneumonia. J Crit Care 2015; 30 (4) 721-726
    CrossrefPubMedGoogle Scholar
  • 16 Sandvall B, Rueda AM, Musher DM. Long-term survival following pneumococcal pneumonia. Clin Infect Dis 2013; 56 (8) 1145-1146
    CrossrefPubMedGoogle Scholar
  • 17 Wunderink RG, Waterer GW. Community-acquired pneumonia. N Engl J Med 2014; 370 (19) 1863
    PubMedGoogle Scholar
  • 18 Mandell LA, Wunderink RG, Anzueto A , et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl. 02) S27-S72
    CrossrefPubMedGoogle Scholar
  • 19 Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CGUS. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 2013; 369 (2) 155-163
    CrossrefPubMedGoogle Scholar
  • 20 Holter JC, Müller F, Bjørang O , et al. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis 2015; 15: 64
    CrossrefPubMedGoogle Scholar
  • 21 Gadsby NJ, Russell CD, McHugh MP , et al. Comprehensive molecular testing for respiratory pathogens in community-acquired Pneumonia. Clin Infect Dis 2016; 62 (7) 817-823
    CrossrefPubMedGoogle Scholar
  • 22 Peto L, Nadjm B, Horby P , et al. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg 2014; 108 (6) 326-337
    CrossrefPubMedGoogle Scholar
  • 23 Nyamande K, Lalloo UG, John M. TB presenting as community-acquired pneumonia in a setting of high TB incidence and high HIV prevalence. Int J Tuberc Lung Dis 2007; 11 (12) 1308-1313
    PubMedGoogle Scholar
  • 24 Stephens DP, Thomas JH, Ward LM, Currie BJ. Melioidosis causing critical illness: a review of 24 years of experience from the Royal Darwin Hospital ICU. Crit Care Med 2016; 44 (8) 1500-1505
    CrossrefPubMedGoogle Scholar
  • 25 Rolim DB, Vilar DC, Sousa AQ , et al. Melioidosis, northeastern Brazil. Emerg Infect Dis 2005; 11 (9) 1458-1460
    CrossrefPubMedGoogle Scholar
  • 26 Hogan C, Wilmer A, Badawi M , et al. Melioidosis in Trinidad and Tobago. Emerg Infect Dis 2015; 21 (5) 902-904
    CrossrefPubMedGoogle Scholar
  • 27 Dance D. Treatment and prophylaxis of melioidosis. Int J Antimicrob Agents 2014; 43 (4) 310-318
    CrossrefPubMedGoogle Scholar
  • 28 Dexter C, Murray GL, Paulsen IT, Peleg AY. Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis. Expert Rev Anti Infect Ther 2015; 13 (5) 567-573
    CrossrefPubMedGoogle Scholar
  • 29 Wu CL, Ku SC, Yang KY , et al. Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in Taiwan. J Formos Med Assoc 2013; 112 (1) 31-40
    CrossrefPubMedGoogle Scholar
  • 30 Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF, Ho PL. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest 2006; 129 (1) 102-109
    CrossrefPubMedGoogle Scholar
  • 31 Peng C, Zong Z, Fan H. Acinetobacter baumannii isolates associated with community-acquired pneumonia in West China. Clin Microbiol Infect 2012; 18 (12) E491-E493
    CrossrefPubMedGoogle Scholar
  • 32 Ong CW, Lye DC, Khoo KL , et al. Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific. Respirology 2009; 14 (8) 1200-1205
    CrossrefPubMedGoogle Scholar
  • 33 Anstey NM, Currie BJ, Withnall KM. Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia. Clin Infect Dis 1992; 14 (1) 83-91
    CrossrefPubMedGoogle Scholar
  • 34 Fishbain J, Peleg AY. Treatment of Acinetobacter infections. Clin Infect Dis 2010; 51 (1) 79-84
    CrossrefPubMedGoogle Scholar
  • 35 Mustafa MI, Al-Marzooq F, How SH, Kuan YC, Ng TH. The use of multiplex real-time PCR improves the detection of the bacterial etiology of community acquired pneumonia. Trop Biomed 2011; 28 (3) 531-544
    PubMedGoogle Scholar
  • 36 Feldman C, Ross S, Mahomed AG, Omar J, Smith C. The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. Respir Med 1995; 89 (3) 187-192
    CrossrefPubMedGoogle Scholar
  • 37 Ko WC, Paterson DL, Sagnimeni AJ , et al. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 2002; 8 (2) 160-166
    CrossrefPubMedGoogle Scholar
  • 38 American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171 (4) 388-416
    CrossrefPubMedGoogle Scholar
  • 39 Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128 (6) 3854-3862
    CrossrefPubMedGoogle Scholar
  • 40 Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med 2008; 168 (20) 2205-2210
    CrossrefPubMedGoogle Scholar
  • 41 Chalmers JD, Rother C, Salih W, Ewig S. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis 2014; 58 (3) 330-339
    CrossrefPubMedGoogle Scholar
  • 42 Dobler CC, Waterer G. Healthcare-associated pneumonia: a US disease or relevant to the Asia Pacific, too?. Respirology 2013; 18 (6) 923-932
    CrossrefPubMedGoogle Scholar
  • 43 Ewig S, Welte T. Adding fuel to the flames? It is time to leave HCAP. Respir Med 2012; 106 (9) 1309-1310
    CrossrefPubMedGoogle Scholar
  • 44 Webb BJ, Dascomb K, Stenehjem E, Dean N. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model. Respir Med 2015; 109 (1) 1-10
    CrossrefPubMedGoogle Scholar
  • 45 Lim WS, Baudouin SV, George RC , et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64 (Suppl. 03) iii1-iii55
    CrossrefPubMedGoogle Scholar
  • 46 Waterer GW, Grayson ML. The United States guidelines for the management of community-acquired pneumonia and their relevance to Australasia. Intern Med J 2007; 37 (12) 789-791
    CrossrefPubMedGoogle Scholar
  • 47 Spindler C, Strålin K, Eriksson L , et al; Community Acquired Pneumonia Working Group of The Swedish Society of Infectious Diseases. Swedish guidelines on the management of community-acquired pneumonia in immunocompetent adults—Swedish Society of Infectious Diseases 2012. Scand J Infect Dis 2012; 44 (12) 885-902
    CrossrefPubMedGoogle Scholar
  • 48 Wiersinga WJ, Bonten MJ, Boersma WG , et al; Dutch Working Party on Antibiotic Policy; Dutch Association of Chest Physicians. SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults. Neth J Med 2012; 70 (2) 90-101
    PubMedGoogle Scholar
  • 49 Drosten C, Günther S, Preiser W , et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348 (20) 1967-1976
    CrossrefPubMedGoogle Scholar
  • 50 Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367 (19) 1814-1820
    CrossrefPubMedGoogle Scholar
  • 51 Waterer G. Controlling epidemic viral infection. Curr Opin Infect Dis 2011; 24 (2) 130-136
    CrossrefPubMedGoogle Scholar
  • 52 Lai S, Qin Y, Cowling BJ , et al. Global epidemiology of avian influenza A H5N1 virus infection in humans, 1997-2015: a systematic review of individual case data. Lancet Infect Dis 2016; 16 (7) e108-e118
    CrossrefPubMedGoogle Scholar
  • 53 Zhu H, Lam TT, Smith DK, Guan Y. Emergence and development of H7N9 influenza viruses in China. Curr Opin Virol 2016; 16: 106-113
    CrossrefPubMedGoogle Scholar
  • 54 Jiao P, Cui J, Song Y , et al. New reassortant H5N6 highly pathogenic avian influenza viruses in Southern China, 2014. Front Microbiol 2016; 7: 754
    PubMedGoogle Scholar
  • 55 Waterer G, Bennett L. Improving outcomes from community-acquired pneumonia. Curr Opin Pulm Med 2015; 21 (3) 219-225
    PubMedGoogle Scholar
  • 56 Walkey AJ, Weinberg J, Wiener RS, Cooke CR, Lindenauer PK. Association of do-not-resuscitate orders and hospital mortality rate among patients with pneumonia. JAMA Intern Med 2016; 176 (1) 97-104
    CrossrefPubMedGoogle Scholar
  • 57 Arnold FW, Wiemken TL, Peyrani P, Ramirez JA, Brock GN ; CAPO authors. Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Respir Med 2013; 107 (7) 1101-1111
    CrossrefPubMedGoogle Scholar
  • 58 Koivula I, Stén M, Mäkelä PH. Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. Arch Intern Med 1999; 159 (14) 1550-1555
    CrossrefPubMedGoogle Scholar
  • 59 Quan TP, Fawcett NJ, Wrightson JM , et al; Infections in Oxfordshire Research Database (IORD). Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998-2014. Thorax 2016; 71 (6) 535-542
    CrossrefPubMedGoogle Scholar
  • 60 Morimoto K, Suzuki M, Ishifuji T , et al; Adult Pneumonia Study Group-Japan (APSG-J). The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study. PLoS ONE 2015; 10 (3) e0122247
    CrossrefPubMedGoogle Scholar
  • 61 Mahboub B, Al Zaabi A, Al Ali OM, Ahmed R, Niederman MS, El-Bishbishi R. Real life management of community-acquired pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study. BMC Pulm Med 2015; 15: 112
    CrossrefPubMedGoogle Scholar
  • 62 Lee JS, Primack BA, Mor MK , et al. Processes of care and outcomes for community-acquired pneumonia. Am J Med 2011; 124 (12) 1175.e9-1175.e17
    CrossrefPubMedGoogle Scholar
  • 63 Tichopad A, Roberts C, Gembula I , et al. Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia. PLoS ONE 2013; 8 (8) e71375
    CrossrefPubMedGoogle Scholar
  • 64 McLaughlin JM, Johnson MH, Kagan SA, Baer SL. Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study. Infection 2015; 43 (6) 671-680
    CrossrefPubMedGoogle Scholar
  • 65 Yu H, Rubin J, Dunning S, Li S, Sato R. Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population. J Am Geriatr Soc 2012; 60 (11) 2137-2143
    PubMedGoogle Scholar
  • 66 Thomas CP, Ryan M, Chapman JD , et al. Incidence and cost of pneumonia in medicare beneficiaries. Chest 2012; 142 (4) 973-981
    CrossrefPubMedGoogle Scholar
  • 67 Li A, Newall AT, Britt H, Macintyre CR. The cost and disease burden of pneumonia in general practice in Australia. Vaccine 2012; 30 (5) 830-831
    CrossrefPubMedGoogle Scholar
  • 68 Monge V, San-Martín VM, González A. The burden of community-acquired pneumonia in Spain. Eur J Public Health 2001; 11 (4) 362-364
    CrossrefPubMedGoogle Scholar
  • 69 Gutiérrez F, Masiá M, Rodríguez JC , et al. Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain. Clin Microbiol Infect 2005; 11 (10) 788-800
    CrossrefPubMedGoogle Scholar
  • 70 Roysted W, Simonsen O, Jenkins A , et al. Aetiology and risk factors of community-acquired pneumonia in hospitalized patients in Norway. Clin Respir J 2015; DOI: 10.1111/crj.12283 .
    PubMedGoogle Scholar
  • 71 Iroezindu MO, Chima EI, Isiguzo GC , et al. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study. Scand J Infect Dis 2014; 46 (12) 875-887
    CrossrefPubMedGoogle Scholar
  • 72 Naderi H, Sheybani F, Sarvghad M, Meshkat Z, Jabbari Nooghabi M. Etiological diagnosis of community-acquired pneumonia in adult patients: a prospective hospital-based study in Mashhad, Iran. Jundishapur J Microbiol 2015; 8 (8) e22780
    PubMedGoogle Scholar
  • 73 Lauderdale TL, Chang FY, Ben RJ , et al. Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan. Respir Med 2005; 99 (9) 1079-1086
    CrossrefPubMedGoogle Scholar
  • 74 Farida H, Gasem MH, Suryanto A , et al. Viruses and Gram-negative bacilli dominate the etiology of community-acquired pneumonia in Indonesia, a cohort study. Int J Infect Dis 2015; 38: 101-107
    CrossrefPubMedGoogle Scholar
  • 75 Charles PG, Whitby M, Fuller AJ , et al; Australian CAP Study Collaboration. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis 2008; 46 (10) 1513-1521
    CrossrefPubMedGoogle Scholar